Description
This blend combines KPV, an anti-inflammatory tripeptide, with SLU-PP-332, a synthetic ERR agonist, in a single lyophilized vial for researchers studying combined inflammatory and metabolic signaling pathways.
| Composition | 10mg KPV · 10mg SLU-PP-332 |
| Format | Lyophilized powder, single vial |
| Purity | ≥98% per component (HPLC verified) |
| Storage | -20°C lyophilized, protected from light; 2-8°C after reconstitution |
Pairing KPV’s anti-inflammatory signaling with SLU-PP-332’s metabolic activity gives researchers a way to look at inflammation and energy metabolism as connected processes rather than studying them on separate tracks.






Reviews
There are no reviews yet.